Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 82

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 82
---
, Israel, 7630242. (3)Consists of (i) 438,169 NLS Common Shares, (ii) 3,474 NLS Common Shares issuable upon exercise of options vested and exercisable within 60 days of August 28, 2025, (iii) 13,054 NLS Common Shares issuable upon exercise of common warrants exercisable within 60 days of August 28, 2025, (iv) 100,807 NLS Common Shares issuable upon exercise of common warrants exercisable within 60 days of August 28, 2025, subject to a beneficial ownership limitation of 9.99%, and (v) 1,925 NLS Common Shares issuable upon exercise of pre -fundedwarrants exercisable within 60 days of August 28, 2025, subject to a beneficial ownership limitation of 4.99%. The beneficial ownership limitation restricts from exercising that portion of the warrants that would result in Mr. Ronald Hafner owning, after exercise, a number of NLS Common Shares in excess of the beneficial ownership limitation. Mr. Hafner is Chairman of NLS Pharmaceutics Ltd. (4)Consists of (i) 2,058,573 NLS Common Shares, (ii) 232,686 Common Shares issuable upon vesting of RSUs and exercisable within 60 days of August 28, 2025, and (iii) 452,224 NLS Common Shares issuable upon exercise of options vested and exercisable within 60 days of August 28, 2025. (5)Consists of 1,742 NLS Common Shares issuable upon exercise of options within 60 days of August 28, 2025. (6)Consists of 1,248 NLS Common Shares. (7)Consists of (i) 48,528 NLS Common Shares, and (ii) 2,787 NLS Common Shares issuable upon exercise of options within 60 days of August 28, 2025. (8)Consists of (i) 8,766,252 NLS Common Shares, and (ii) 207,913 NLS Common Shares issuable upon exercise of common warrants exercisable within 60 days of August 28, 2025, subject to a beneficial ownership limitation of 9.99%. The beneficial ownership limitation restricts from exercising that portion of the warrants that would